Physiotherapy in Women's Health Research Group

The group's mission is to promote the growth of physiotherapy in women's health, promoting beneficial behaviors in the health and well-being of women with the vision of being the benchmark in Physiotherapy in Women's Health. The values of the FPSM Research Group are commitment, trust and innovation with the purpose of transferring clinical research in women's health to society, making it accessible to all women.

The main lines of research are developed within two large sections, the clinical section (physiotherapy in physiological processes such as pregnancy and menopause, and in pathophysiological processes, such as pelvic floor dysfunctions, oncological conditions and their different sequelae, and pain in women) and the educational section (therapeutic and health education, teaching innovation and service learning).

Activity indicators 2025

1 competitive national public project: ISCIII
4 clinical trials
3 competitive HR contracts
10 publications
FI: 29.90
Q1 publications: 6 (60%)
Publications in D1: 1 (10%)
3 doctoral theses supervised and defended
1 award
Project evaluators: 1 PI and 1 researcher
< 1 month spent at international centers: National Research Centre for the Working Environment (Denmark)
1 visiting student and 1-month stay: State University of Santa Catarina (Brazil)

Milestones

Granting of Spanish patent ES2994458B2 titled "Intravaginal Device for Pelvic Floor Muscle Training," developed by the group for the functional monitoring of pelvic floor muscles, consolidating a strategic line of technological innovation with high potential for clinical and healthcare applications.
Publication of the PILME clinical trial protocol in an indexed international journal. The protocol for the randomized PILME clinical trial was published in BMJ Open, focusing on the evaluation of a multimodal approach to pelvic floor physical therapy in women with menopausal genitourinary syndrome induced by cancer treatments.
Publication of the RASDOP study protocol in a Q1 journal. The RASDOP study protocol was published in the *Journal of Clinical Medicine*, aimed at evaluating the effectiveness of radiofrequency integrated into a multimodal physical therapy program for the treatment of postpartum pelvic-perineal pain.
Awarded the 20th Prize from the Social Council of the University of Alcalá for Knowledge Transfer. This award, in the Biomedical and Health Sciences category, highlights the clinical, social, and innovative impact of the "Early Postpartum Physical Therapy 4.0" research line.
Strengthening research activities through the development of active competitive projects in pelvic health and oncology. Throughout 2025, the group maintained active competitive projects in technological innovation, postpartum pelvic pain, and cancer-related sequelae, thereby strengthening its capacity for translational clinical research in collaboration with the hospital community.